Puneet K. Bansal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Puneet K. Bansal has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Chase J. Wehrle
Department of General Surgery, Cleveland Clinic, Digestive Diseases and Surgery Institute, Cleveland, OH, USA
2 shared publications Abby Gross
1 shared publication- Abdul Rafeh Awan
Department of Surgery, Nishtar Medical University, Multan, Pakistan
1 shared publication Agha Wali
Banner University Medical Center
1 shared publication- Akul Arora
Department of Surgery, University Hospitals Cleveland Medical Center, Cleveland, Ohio
1 shared publication - Alfred Hausladen
Institute for Transformative Molecular Medicine, Department of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA
1 shared publication
Latest Publications
- Open Access
- 14 October 2026
- Published by Elsevier in Pancreatology
Risk assessment of multi-focal side-branch IPMNs: Long-term follow-up of one thousand patients
- 14 October 2026
- Published by Elsevier in Pancreatology
Open AccessRisk assessment of multi-focal side-branch IPMNs: Long-term follow-up of one thousand patients
- 27 August 2026
- Published by Taylor & Francis in Baylor University Medical Center Proceedings
- Vol. 39 (6) , 965-977
Demographics and factors influencing mortality among cardiac angiosarcoma patients and genomic studies correlation for future personalized management
Cardiac angiosarcoma is an exceedingly rare and aggressive malignancy of the epithelial cells that line the blood vessels in cardiac tissue.1 It has an incidence rate of approximately 0.017%, most ...
- 27 August 2026
- Published by Taylor & Francis in Baylor University Medical Center Proceedings
- Vol. 39 (6) , 965-977
Demographics and factors influencing mortality among cardiac angiosarcoma patients and genomic studies correlation for future personalized management
Cardiac angiosarcoma is an exceedingly rare and aggressive malignancy of the epithelial cells that line the blood vessels in cardiac tissue.1 It has an incidence rate of approximately 0.017%, most ...
- Open Access
- 29 June 2026
- Published by Elsevier in Journal of Surgical Research
- Vol. 325, 525-532
Geographic Impact of Surgical Conferences on Travel Burden and Carbon Emissions: Multisociety Study
- 29 June 2026
- Published by Elsevier in Journal of Surgical Research
- Vol. 325, 525-532
Open AccessGeographic Impact of Surgical Conferences on Travel Burden and Carbon Emissions: Multisociety Study
- 23 December 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 18 (918) , eadv0660
The protein denitrosylase SCoR2 regulates lipogenesis and fat storage
Lipid homeostasis is subject to control by posttranslational modification machinery, such as sirtuin deacetylases that reverse coenzyme A (CoA)–dependent acetylation. Here, we showed that a mammalian denitrosylase (SCoR2), which counteracts CoA-dependent S-nitrosylation, promoted both fat storage and lipogenesis to impair metabolic health. In mice, SCoR2 protein abundance correlated with body mass, and deleting or pharmacologically inhibiting SCoR2 prevented both diet-induced obesity and metabolic dysfunction–associated steatotic liver disease (MASLD). Loss of SCoR2 in adipocytes promoted the S-nitrosylation of the actin cytoskeletal regulator myosin 9, which inhibited the activity of the lipogenesis-promoting transcription factors PPARγ, SREBP1, and CEBPα to prevent fat storage. In hepatocytes, inhibition of SCoR2-mediated denitrosylation of lipogenic enzymes reduced fat synthesis and induced fat oxidation. In humans, an obesity-linked polymorphism was associated with increased SCoR2 mRNA expression, and in patient adipose and liver tissues, SCoR2 protein or mRNA abundance directly correlated with adipocyte size or MASLD. These results indicate that SCoR2 regulates nutrient metabolism, similar to sirtuins, and is a potential drug target for obesity and MASLD.
- 23 December 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 18 (918) , eadv0660
The protein denitrosylase SCoR2 regulates lipogenesis and fat storage
Lipid homeostasis is subject to control by posttranslational modification machinery, such as sirtuin deacetylases that reverse coenzyme A (CoA)–dependent acetylation. Here, we showed that a mammalian denitrosylase (SCoR2), which counteracts CoA-dependent S-nitrosylation, promoted both fat storage and lipogenesis to impair metabolic health. In mice, SCoR2 protein abundance correlated with body mass, and deleting or pharmacologically inhibiting SCoR2 prevented both diet-induced obesity and metabolic dysfunction–associated steatotic liver disease (MASLD). Loss of SCoR2 in adipocytes promoted the S-nitrosylation of the actin cytoskeletal regulator myosin 9, which inhibited the activity of the lipogenesis-promoting transcription factors PPARγ, SREBP1, and CEBPα to prevent fat storage. In hepatocytes, inhibition of SCoR2-mediated denitrosylation of lipogenic enzymes reduced fat synthesis and induced fat oxidation. In humans, an obesity-linked polymorphism was associated with increased SCoR2 mRNA expression, and in patient adipose and liver tissues, SCoR2 protein or mRNA abundance directly correlated with adipocyte size or MASLD. These results indicate that SCoR2 regulates nutrient metabolism, similar to sirtuins, and is a potential drug target for obesity and MASLD.
- Open Access
- 9 October 2025
- Published by Elsevier in eClinicalMedicine
- Vol. 89, 103560
Role of antibiotic prophylaxis in liver transplant patients undergoing endoscopic retrograde cholangiopancreatography: a systematic review and meta-analysis
- 9 October 2025
- Published by Elsevier in eClinicalMedicine
- Vol. 89, 103560
Open AccessRole of antibiotic prophylaxis in liver transplant patients undergoing endoscopic retrograde cholangiopancreatography: a systematic review and meta-analysis